FGFR2 and urinary bladder cancer: In rat prostate and bladder cancer models it has been indicated a switch from FGFR-2-IIIb to FGFR-2-IIIc isoform [17], [18], which might contribute to alter the balance between epithelial and mesenchymal cells and to promote epithelial-mesenchymal transition.